Related Experiment Video
Updated: Jan 4, 2026
06:51
Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
8.1K
MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy
Arturo López Castel1,2, Sarah Joann Overby1,2, Rubén Artero1,2
1Translational Genomics Group, Incliva Health Research Institute, Burjassot, 46100 Valencia, Spain.
International Journal of Molecular Sciences
|November 14, 2019
Summary
Myotonic dystrophy (DM) involves RNA metabolism defects. This review explores how microRNAs (miRNAs) can therapeutically restore MBNL and CELF1 protein function, offering new treatment strategies for DM.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Myotonic dystrophy (DM), encompassing DM1 and DM2, is a rare neuromuscular disease characterized by RNA metabolism dysregulation.
- Key molecular events include Muscleblind-like (MBNL) protein sequestration and altered CUGBP RNA-Binding Protein Elav-Like Family Member 1 (CELF1) function.
- These disruptions significantly impact RNA processing, contributing to DM's clinical manifestations.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in myotonic dystrophy.
- To explore the therapeutic potential of modulating miRNAs to restore MBNL and CELF1 protein function.
- To discuss prospective miRNA targets, biomarker applications, and drug development strategies for DM.
Main Methods:
- Literature review focusing on recent findings regarding miRNAs in DM.
- Analysis of miRNA involvement in MBNL and CELF1 protein regulation.
- Discussion of therapeutic strategies based on miRNA modulation.
Main Results:
- MicroRNAs are implicated in the pathogenesis of myotonic dystrophy.
- Modulating specific miRNAs offers a potential therapeutic avenue to correct MBNL and CELF1 dysfunction.
- miRNAs show promise as biomarkers and targets for novel drug development in DM.
Conclusions:
- MicroRNA-based therapies represent a promising strategy for treating myotonic dystrophy.
- Further research into miRNA targets and drug development is warranted.
- miRNAs can serve as valuable biomarkers for DM diagnosis and progression.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
01:22MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
01:22MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
01:29Microorganisms in Medicine and Therapeutics
893
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
893
01:13Formation of Muscle Fibers from Myoblasts
5.7K
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
5.7K
01:20Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K